Skip to main content
Veterinary Medicines

LABHIDRO AD3E SOLUCION INYECTABLE

Authorised
  • DL-ALPHA TOCOPHEROL ACETATE
  • Colecalciferol
  • Retinol

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    75000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    500000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Farmacevtska oblika:
  • Raztopina za injiciranje
Withdrawal period by route of administration:
  • Intramuscular use
    • govedo
      • Meat and offal
        280
        day
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        243
        day
      • Milk
        no withdrawal period
    • Horse
      • Meat and offal
        280
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        259
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QA11JA
Status dovoljenja:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Labiana Life Sciences S.A.
Pristojni organ:
  • Spanish Agency For Medicines And Health Products
Številka dovoljenja :
  • 3668 ESP
Datum spremembe statusa dovoljenja:

Dokumenti

Povzetek glavnih značilnosti zdravila

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Spanish (PDF)
Objavljeno na: 30/11/2023

Navodilo za uporabo

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Spanish (PDF)
Objavljeno na: 30/11/2023

Označevanje

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Spanish (PDF)
Objavljeno na: 30/11/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."